With pharmacological induction of the expression of Shh in epithelial tumor cells of the basal subtype, which in turn increases the stromal Hh response, urothelial carcinoma develops into a less aggressive, more manageable luminal-like subtype of bladder cancer through stromally produced Bmp-mediated cellular differentiation. This evidence concerns the gene SHH and urothelial carcinoma.